Action USNU U.S. NEUROSURGICAL HOLDINGS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues U.S. NeuroSurgical Holdings, Inc.

Actions

USNU

US90336K1016

Marché Fermé - OTC Markets
Autres places de cotation
 16:56:57 24/04/2024 		Varia. 5j. Varia. 1 janv.
0,714 USD -4,80 % Graphique intraday de U.S. NeuroSurgical Holdings, Inc. -0,83 % +58,67 %
05/04 U.S. NeuroSurgical Holdings, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 U.S. NeuroSurgical Holdings, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
U.S. NEUROSURGICAL HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
U.S. NeuroSurgical Holdings, Inc. Appoints William St. Lawrence as a Non-Executive Director
U.S. NEUROSURGICAL HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NEUROSURGICAL HOLDINGS, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action USNU
  4. Actualités U.S. NeuroSurgical Holdings, Inc.
  5. Autres langues